A new estimate of the ghostly particle’s maximum possible mass brings physicists a tad closer to understanding the universe. By Katrina Miller Katrina Miller studied neutrinos in graduate school, but ...

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...

For more than a century, a single metal cylinder in a Paris vault quietly defined what a kilogram was. After 130 years, ...

Physicists have spent decades treating mass as something the universe simply hands to particles, a property encoded in equations rather than explained from first principles. A new proposal argues that ...

Please provide your email address to receive an email when new articles are posted on . Adding bimagrumab 30 mg/kg to semaglutide 2.4 mg conferred weight loss of more than 20% at 72 weeks in patients ...

Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat obesity. Iuliia Burmistrova/Getty Images GLP-1 drugs have helped people successfully achieve and ...

With glucagon-like peptide 1 (GLP-1) agonists now close to inducing weight loss at levels only seen before through surgical intervention, obesity specialists say patients on these drugs are ...